About: BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Huet Sarah, Szafer-Glusman Edith, Tesson Bruno, Xerri Luc, Fairbrother Wayne J., Mukhyala Kiran, Bolen Chris, Punnoose Elizabeth, Tonon Laurie, Chassagne-Clément Catherine, Feugier Pierre, Viari Alain, Jardin Fabrice, Salles Gilles, Sujobert Pierre. BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab. American Journal of Hematology, Wiley, 2017, 92 (6), pp.515 - 519. ⟨10.1002/ajh.24701⟩
  • Huet Sarah, Szafer-Glusman Edith, Tesson Bruno, Xerri Luc, Fairbrother Wayne J., Mukhyala Kiran, Bolen Chris, Punnoose Elizabeth, Tonon Laurie, Chassagne-Clément Catherine, Feugier Pierre, Viari Alain, Jardin Fabrice, Salles Gilles, Sujobert Pierre . BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab . American Journal of Hematology, 2017, 92 (6), pp.515 - 519 . ⟨10.1002/ajh.24701⟩
Title
  • BCL2 mutations do not confer adverse prognosis in follicular lymphoma patients treated with rituximab
dc:date
  • 2017
Digital Object Identifier (DOI)
  • 10.1002/ajh.24701
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software